Keywords
Low carb
Intermittent fasting
Hypocaloric diet
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: The present study aimed to evaluate and compare the effects of intermittent fasting, low carb and hypocaloric diets on weight control, lean and lipid mass and lipid and glycemic profiles in obese volunteers. Methods: This is a randomized clinical trial in which the sample consisted of a 30 individuals group, of both sexes, aged between 18 and 40 years with Body Mass Index (BMI) > 25 kg/m² and with similar organic conditions in which they were divided into 3 groups and submitted to the above mentioned diets for 30 days. Results: The results revealed by anthropometry, bioimpedance and laboratory tests show that when the values in the groups are compared separately, we have significant variables. Conclusion: Thus, the hypocaloric diet showed better results, mainly in weight and BMI (body mass index), which helps to control possible patient comorbidities. And in relation to laboratory tests, the Low carb diet and intermittent fasting had good results with reduced levels of blood glucose, total cholesterol, triglycerides, High-density lipoprotein (HDL), Low-density lipoprotein (LDL) and Very low-density lipoprotein (VLDL).
References
ADAM-PERROT A, et al. Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev., 2006; 7(1): 49-58.
ANTONI R, et al. Effects of intermittent fasting on glucose and lipid metabolism. Proc Nutr Soc., 2017; 76(3): 361-368.
ASTRUP A e HJORTH MF. Low-Fat or Low Carb for Weight Loss? It Depends on Your Glucose Metabolism. EBioMedicine, 2017; 22: 20-21.
BONFANTI N, et al. Efecto de dos dietas hipocalóricas y su combinación con ejercicio físico sobre la tasa metabólica basal y la composición corporal. Nutr. Hosp. [Internet], 2014; 29(3): 635-643.
CABALLERO B. Humans against Obesity: Who Will Win? Adv Nutr., 2019; 10(suppl_1): S4-S9.
CERCATO C. Diretrizes brasileiras de obesidade 2016 / ABESO - Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. – 4.ed. - São Paulo, SP.
CHRISTENSEN RAG, et al. Sequential diets and weight loss: Including a low-carbohydrate high-fat diet with and without time-restricted feeding. Nutrition, 2021; 91-92: 111393.
DE PERGOLA G, et al. Effects of a Low Carb Diet and Whey Proteins on Anthropometric, Hematochemical, and Cardiovascular Parameters in Subjects with Obesity. Endocrine, metabolic & immune disorders drug targets, 2020; 20(10): 1719-1725.
DURRER SD, et al. European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care. Obes Facts, 2019; 12(1): 40-66.
FREIRE R. Scientific evidence of diets for weight loss: Different macronutrient composition, intermittent fasting, and popular diets. Nutrition, 2020; 69: 110549.
HANKEY C. Fad diets and fasting for weight loss in obesity. In: Chichester, West Sussex; Hoboken, NJ: John Wiley & Sons. Advanced nutrition and dietetics in obesity. 1 th ed. London, UK: King's College London, 2018: 85-137.
JESUS J, et al. O processo de trabalho na Estratégia Saúde da Família voltado às pessoas com sobrepeso e obesidade em São Paulo. Saúde em Debate [online], 2022; 46(132): 175-187.
KACHUR S, et al. Obesity and cardiovascular diseases. Minerva Med., 2017; 108(3): 212-228.
KEENAN S, et al. The Effects of Intermittent Fasting Combined with Resistance Training on Lean Body Mass: A Systematic Review of Human Studies. Nutrients, 2020; 12(8): 2349.
KLEMENT RJ, et al. Impact of a ketogenic diet intervention during radiotherapy on body composition: III-final results of the KETOCOMP study for breast cancer patients. Breast Cancer Res., 2020; 20; 22(1): 94.
LANGSTED A e NORDESTGAARDN BG. Nonfasting versus fasting lipid profile for cardiovascular risk prediction. Pathology, 2019; 51(2): 131-141.
MACHADO ACSB. Manipulação de carboidratos associado a treinamento físico contínuo e intermitente em indivíduos com excesso de peso. Dissertação (Pós-Graduação em Educação Física) - Universidade Federal de Sergipe, São Cristóvão, 2016; 78.
NAZATTO MFS, et al. Comparação entre os efeitos da dieta low carb e do jejum intermitente no processo de emagrecimento: síntese de evidências. International Journal of Health Management Review, 2020; 6: 1.
MAYORAL LP, et al. Obesity subtypes, related biomarkers & heterogeneity. Indian J Med Res., 2020; 151(1): 11-21.
R DEVELOPMENT CORE TEAM. A language and environment for statistical computing. 2020. Available: https://www.r-project.org/.
RIOBÓ S. Pautas dietéticas en la diabetes y en la obesidad [Diet recomendations in diabetes and obesity]. Nutr Hosp., 2018; 12(35): 109-115.
SARTORIO A, et al Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis. Eur J Clin Nutr., 2005; 59(2): 155-60.
SEID H e ROSENBAUM M. Low Carbohydrate and Low-Fat Diets: What We Don't Know and Why we Should Know It. Nutrients, 2019; 11(11): 2749.
VARADY KA. Intermittent versus daily calorie restriction: which diet regimen is more effective for weight loss? Obes Rev., 2011; 12(7): 593-601.
VARGAS AJ, et al. Jejum intermitente e dieta Low Carb na composição corporal e no comportamento alimentar de mulheres praticantes de atividade física. Revista Brasileira de Nutrição Esportiva, 2018; 12(72): 483-490.
WANG LL, et al. The Effect of Low-Carbohydrate Diet on Glycemic Control in Patients with Type 2 Diabetes Mellitus. Nutrients, 2018; 10(6): 661.
WELTON S, et al. Intermittent fasting and weight loss: Systematic review. Can Fam Physician, 2020; 66(2): 117-12.
WILLOUGHBY D, et al. Body Composition Changes in Weight Loss: Strategies and Supplementation for Maintaining Lean Body Mass, a Brief Review. Nutrients, 2018; 10(12): 1876.
ZUBRZYCKI A, et al. The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes. J Physiol Pharmacol., 2018; 69(5).